ODT
Charles Schwab’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-19,636
| Closed | -$27K | – | 3679 |
|
|
2021
Q4 | $27K | Hold |
19,636
| – | – | ﹤0.01% | 3564 |
|
|
2021
Q3 | $58K | Sell |
19,636
-60,800
| -76% | -$180K | ﹤0.01% | 3435 |
|
|
2021
Q2 | $281K | Sell |
80,436
-49,618
| -38% | -$173K | ﹤0.01% | 3248 |
|
|
2021
Q1 | $445K | Buy |
130,054
+5,784
| +5% | +$19.8K | ﹤0.01% | 3118 |
|
|
2020
Q4 | $2.39M | Buy |
124,270
+36,614
| +42% | +$703K | ﹤0.01% | 2546 |
|
|
2020
Q3 | $1.18M | Buy |
87,656
+6,234
| +8% | +$83.8K | ﹤0.01% | 2638 |
|
|
2020
Q2 | $3.45M | Buy |
81,422
+14,592
| +22% | +$618K | ﹤0.01% | 2201 |
|
|
2020
Q1 | $1.85M | Sell |
66,830
-4,047
| -6% | -$112K | ﹤0.01% | 2302 |
|
|
2019
Q4 | $2.3M | Buy |
70,877
+1,736
| +3% | +$56.3K | ﹤0.01% | 2373 |
|
|
2019
Q3 | $1.8M | Buy |
69,141
+13,936
| +25% | +$363K | ﹤0.01% | 2415 |
|
|
2019
Q2 | $2.03M | Buy |
55,205
+1,150
| +2% | +$42.2K | ﹤0.01% | 2366 |
|
|
2019
Q1 | $1.2M | Buy |
54,055
+5,566
| +11% | +$123K | ﹤0.01% | 2505 |
|
|
2018
Q4 | $683K | Buy |
48,489
+2,825
| +6% | +$39.8K | ﹤0.01% | 2656 |
|
|
2018
Q3 | $887K | Buy |
45,664
+11,527
| +34% | +$224K | ﹤0.01% | 2659 |
|
|
2018
Q2 | $754K | Buy |
34,137
+5,601
| +20% | +$124K | ﹤0.01% | 2669 |
|
|
2018
Q1 | $605K | Buy |
+28,536
| New | +$605K | ﹤0.01% | 2682 |
|